Dr Yassine Amrani, a trained researcher in respiratory medicine, received his MSc and PhD degrees (summa com laude) from the University “Louis Pasteur” of Strasbourg in France. He received his first academic appointment at the prestigious University of Pennsylvania in Philadelphia, one of the top Ivy League Universities in the USA. He is currently Reader (Associate Professor) in Respiratory Immunology at the University of Leicester. Dr Amrani is among the first in the field to have suggested the new concept that pro-asthmatic cytokines contribute to the impaired lung function in severe asthma by directly altering airway smooth muscle function. These studies led to the design of later clinical trials that have used anti-TNF therapies as a potential treatment for severe asthma. Dr Amrani’s current research focuses providing novel alternatives to rescue asthmatic patients who are refractory to current therapies. Dr Yassine Amrani received different research grants from National Institute of Health (USA), American Lung Association and the esteemed Parker B. Francis foundation. He published over 67 peer-reviewed articles/reviews in top medical journals, and 7 book chapters in pulmonary medicine. He delivered over 35 lectures in different Universities and chaired a number of scientific sessions at international conferences including the American Thoracic Society and American Academy of Allergy Asthma and Immunology. Dr Amrani trained more than 10 post-doctoral fellows (PhD scientists and PhD-MD pulmonary fellows) who are currently holding faculty positions at different prestigious universities in the United States. He served as reviewer for funding bodies including NIH/FAMRI (USA), Canadian Lung Association, and Wellcome Trust, MRC, BLF, and Asthma UK (UK) and at least 21 prestigious medical journals. He is a member of the American Society for Pharmacology and Experimental Therapeutics, the American Association of Immunologists and American Physiological Society.
Biography Updated on 26 December 2010